ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Treatment of Duchenne muscular dystrophy with cyclosporin A – A randomized, double-blind, placebo controlled trial
Neuropediatrics
◽
10.1055/s-0029-1215757
◽
2008
◽
Vol 39
(05)
◽
Author(s):
J Kirschner
◽
J Schessl
◽
G Ihorst
◽
R Korinthenberg
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Cyclosporin A
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.725296619.793535821
◽
2017
◽
Author(s):
WH Wilson Tang
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial
Orphanet Journal of Rare Diseases
◽
10.1186/s13023-019-1066-9
◽
2019
◽
Vol 14
(1)
◽
Cited By ~ 4
Author(s):
Sven Dittrich
◽
◽
Erika Graf
◽
Regina Trollmann
◽
Ulrich Neudorf
◽
...
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Left Ventricular Dysfunction
◽
Ace Inhibitor
◽
Ventricular Dysfunction
◽
Controlled Trial
◽
Left Ventricular
◽
Double Blind
◽
Double Blind Placebo
◽
Β Blocker
Download Full-text
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial
The Lancet Neurology
◽
10.1016/s1474-4422(14)70318-7
◽
2015
◽
Vol 14
(2)
◽
pp. 153-161
◽
Cited By ~ 99
Author(s):
Subha V Raman
◽
Kan N Hor
◽
Wojciech Mazur
◽
Nancy J Halnon
◽
John T Kissel
◽
...
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
P.11.18 Design of a confirmatory phase 3, multicenter, randomized, double-blind, placebo-controlled study of ataluren in patients with nonsense mutation Duchenne muscular dystrophy
Neuromuscular Disorders
◽
10.1016/j.nmd.2013.06.579
◽
2013
◽
Vol 23
(9-10)
◽
pp. 804
Author(s):
J. Barth
◽
A. Reha
◽
R. Spiegel
◽
G.L. Elfring
◽
M. Husain
◽
...
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Nonsense Mutation
◽
Controlled Study
◽
Phase 3
◽
Double Blind
◽
Double Blind Placebo
◽
Confirmatory Phase
Download Full-text
T.O.3 SNT-MC17/idebenone in Duchenne muscular dystrophy: long-term blinded controlled preclinical study in the mdx mouse followed by a 12 month double-blind randomized controlled trial in humans
Neuromuscular Disorders
◽
10.1016/j.nmd.2008.06.378
◽
2008
◽
Vol 18
(9-10)
◽
pp. 832
◽
Cited By ~ 3
Author(s):
G.M. Buyse
◽
N. Goemans
◽
G. Van der Mieren
◽
M. Erb
◽
J. D’hooge
◽
...
Keyword(s):
Randomized Controlled Trial
◽
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Controlled Trial
◽
Preclinical Study
◽
Mdx Mouse
◽
Double Blind
◽
Randomized Controlled
Download Full-text
Effect and Safety of Treatment with ACE-Inhibitor Enalapril and β-Blocker Metoprolol on the Onset of Left Ventricular Dysfunction in Duchenne Muscular Dystrophy: Results from a Six Years, Double-blind, Randomized Placebo-controlled Trial
10.1055/s-0038-1628322
◽
2018
◽
Author(s):
S. Dittrich
◽
E. Graf
◽
U. Neudorf
◽
A. Heilmann
◽
U. Schara
◽
...
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Left Ventricular Dysfunction
◽
Ace Inhibitor
◽
Ventricular Dysfunction
◽
Controlled Trial
◽
Left Ventricular
◽
Double Blind
◽
Β Blocker
Download Full-text
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet
◽
10.1016/s0140-6736(17)31611-2
◽
2017
◽
Vol 390
(10101)
◽
pp. 1489-1498
◽
Cited By ~ 157
Author(s):
Craig M McDonald
◽
Craig Campbell
◽
Ricardo Erazo Torricelli
◽
Richard S Finkel
◽
Kevin M Flanigan
◽
...
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Nonsense Mutation
◽
Phase 3
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
FRI0021 Combination therapy with cyclosporin-a and methotrexate in patients with early potentially aggressive rheumatoid arthritis, a randomised double blind placebo controlled trial
10.1136/annrheumdis-2001.1150
◽
2001
◽
Author(s):
AH Gerards
◽
RB Landewé
◽
AP Prins
◽
GA Bruijn
◽
HS Goei Thé
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Combination Therapy
◽
Cyclosporin A
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double‐blind, placebo‐controlled, dose‐titration trial
Muscle & Nerve
◽
10.1002/mus.27347
◽
2021
◽
Author(s):
Kathryn R. Wagner
◽
Nancy L. Kuntz
◽
Erica Koenig
◽
Lilly East
◽
Sameer Upadhyay
◽
...
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Dose Titration
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Faculty Opinions recommendation of Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.727824728.793536094
◽
2017
◽
Author(s):
Manoj Menezes
Keyword(s):
Duchenne Muscular Dystrophy
◽
Muscular Dystrophy
◽
Nonsense Mutation
◽
Phase 3
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close